Literature DB >> 25457217

[Superior vena cava syndrome with malignant causes].

S Bellefqih1, J Khalil2, I Mezouri2, M Afif2, S Elmajjaoui2, T Kebdani2, N Benjaafar2.   

Abstract

Superior vena cava syndrome comprises various symptoms and signs resulting from the obstruction of the superior vena cava and resulting in reduced blood flow. Superior vena cava may occur secondary to a variety of conditions, but malignant etiologies are the most common. Usually, the diagnosis is based on a quite clear clinical presentation. Patient with acute presentation can develop life-threatening complications such as cerebral or laryngeal edema. In the absence of these two conditions, a histologic diagnosis should be obtained before the initiation of any therapy. Management of superior vena cava syndrome requires a multidisciplinary team. Therapeutic approaches include radiotherapy, chemotherapy and endovascular approach, and the choice of therapy will depend on the severity of the symptoms, the type and the stage of the tumor, but also the patient's general condition.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Chimiothérapie; Malignant; Radiotherapy; Radiothérapie; Superior vena cava syndrome; Syndrome cave supérieur; Traitement endovasculaire; Tumoral; Venous stenting

Mesh:

Year:  2014        PMID: 25457217     DOI: 10.1016/j.pneumo.2014.08.001

Source DB:  PubMed          Journal:  Rev Pneumol Clin        ISSN: 0761-8417


  3 in total

1.  Management of superior vena cava syndrome in critically ill cancer patients.

Authors:  Sarah Morin; Adeline Grateau; Danielle Reuter; Eric de Kerviler; Constance de Margerie-Mellon; Cédric de Bazelaire; Lara Zafrani; Benoit Schlemmer; Elie Azoulay; Emmanuel Canet
Journal:  Support Care Cancer       Date:  2017-08-24       Impact factor: 3.603

2.  Vena cava superior syndrome in the children with mediastinal tumors: Single-center experience.

Authors:  Alper Ozcan; Ekrem Unal; Musa Karakukcu; Abdulhakim Coskun; Mehmet Akif Ozdemir; Turkan Patiroglu
Journal:  North Clin Istanb       Date:  2020-04-09

3.  Clinical analysis of 48 cases of malignant superior vena cava syndrome.

Authors:  Lin Wang; Dianyuan Li; Manzhen Sun; Xiaoli Chen; Hongfei Li; Xudong Zhang; Xiaofei Wang; Ruipan Zheng; Guowen Li
Journal:  World J Surg Oncol       Date:  2021-06-23       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.